U.S. Sees Surge in GLP-1 Agonist Use Amid Metabolic Advancements | Retatrutide News

GLP-1 agonist usage in the U.S. has reached new highs, indicating increased demand for these treatments. Eli Lilly's Retatrutide is part of this growing...
Market News · November 1, 2026